Your browser doesn't support javascript.
loading
Chronic Treatment With an Erythropoietin Receptor Ligand Prevents Chronic Kidney Disease-Induced Enlargement of Myocardial Infarct Size.
Nishizawa, Keitaro; Yano, Toshiyuki; Tanno, Masaya; Miki, Takayuki; Kuno, Atsushi; Tobisawa, Toshiyuki; Ogasawara, Makoto; Muratsubaki, Shingo; Ohno, Kouhei; Ishikawa, Satoko; Miura, Tetsuji.
Afiliação
  • Nishizawa K; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Yano T; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Tanno M; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Miki T; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Kuno A; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Tobisawa T; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Ogasawara M; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Muratsubaki S; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Ohno K; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Ishikawa S; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan.
  • Miura T; Departments of Cardiovascular, Renal, and Metabolic Medicine (K.N., T.Y., M.T., T.M., A.K., T.T., M.O., S.M., K.O., S.I., T.M.) and Pharmacology (A.K.), Sapporo Medical University School of Medicine, Japan. miura@sapmed.ac.jp.
Hypertension ; 68(3): 697-706, 2016 09.
Article em En | MEDLINE | ID: mdl-27456523
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Traumatismo por Reperfusão Miocárdica / Eritropoetina / Insuficiência Renal Crônica / Proteínas Proto-Oncogênicas c-akt / Infarto do Miocárdio Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Traumatismo por Reperfusão Miocárdica / Eritropoetina / Insuficiência Renal Crônica / Proteínas Proto-Oncogênicas c-akt / Infarto do Miocárdio Idioma: En Ano de publicação: 2016 Tipo de documento: Article